FMS vs. AGL, DVA, SHC, PGNY, SNN, TECH, PEN, SRPT, INCY, and AVTR
Should you be buying Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? The main competitors of Fresenius Medical Care AG & Co. KGaA include agilon health (AGL), DaVita (DVA), Sotera Health (SHC), Progyny (PGNY), Smith & Nephew (SNN), Bio-Techne (TECH), Penumbra (PEN), Sarepta Therapeutics (SRPT), Incyte (INCY), and Avantor (AVTR). These companies are all part of the "medical" sector.
Fresenius Medical Care AG & Co. KGaA vs.
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and agilon health (NYSE:AGL) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings.
5.6% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 3.3% of agilon health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Fresenius Medical Care AG & Co. KGaA has a net margin of 3.06% compared to agilon health's net margin of -2.88%. Fresenius Medical Care AG & Co. KGaA's return on equity of 5.44% beat agilon health's return on equity.
Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.45, suggesting a potential upside of 28.21%. agilon health has a consensus price target of $31.13, suggesting a potential upside of 51.17%. Given agilon health's stronger consensus rating and higher possible upside, analysts plainly believe agilon health is more favorable than Fresenius Medical Care AG & Co. KGaA.
Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than agilon health. agilon health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.
In the previous week, agilon health had 2 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 5 mentions for agilon health and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.33 beat agilon health's score of 0.48 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.
Fresenius Medical Care AG & Co. KGaA received 348 more outperform votes than agilon health when rated by MarketBeat users. However, 60.32% of users gave agilon health an outperform vote while only 53.46% of users gave Fresenius Medical Care AG & Co. KGaA an outperform vote.
Fresenius Medical Care AG & Co. KGaA has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, agilon health has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500.
Summary
Fresenius Medical Care AG & Co. KGaA beats agilon health on 10 of the 18 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Fresenius Medical Care AG & Co. KGaA Competitors List
Related Companies and Tools